导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -19.95% | 991/1050 |
| 近一周 | -2.63% | 680/1104 |
| 近一月 | -3.76% | 454/1102 |
| 近一季 | -7.05% | 526/1092 |
| 近半年 | -23.16% | 1019/1070 |
| 近一年 | -21.93% | 931/1018 |
| 近两年 | 18.80% | 788/926 |
| 近三年 | 3.19% | 644/834 |
| 成立以来 | 203.50% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.33% 771/1070 |
-13.20% 979/1101 |
- - |
- - |
| 2025 | 21.53% 638/1065 |
1.67% 669/1014 |
7.18% 187/1038 |
17.61% 677/1050 |
-5.18% 711/1065 |
| 2024 | 12.80% 223/1011 |
-2.21% 431/960 |
2.41% 176/983 |
11.47% 505/991 |
1.05% 272/1011 |
| 2023 | 5.67% 42/952 |
13.18% 65/880 |
1.54% 112/895 |
-3.03% 203/915 |
-5.18% 528/952 |
| 2022 | -21.99% 409/867 |
-21.53% 607/773 |
5.09% 518/806 |
-10.96% 299/845 |
6.23% 157/867 |
| 2021 | 17.13% 168/740 |
4.41% 55/580 |
9.66% 365/659 |
-11.51% 542/704 |
15.61% 21/740 |
| 2020 | 79.97% 91/554 |
1.06% 132/419 |
26.38% 177/466 |
28.43% 11/517 |
9.72% 368/554 |
| 2019 | 52.49% 132/410 |
26.81% 561/1146 |
-1.18% 454/1228 |
6.97% 163/390 |
13.77% 75/410 |
| 2018 | -22.59% 107/349 |
- - |
-4.96% 184/990 |
-9.66% 744/1000 |
-12.54% 663/1080 |
| 2017 | 30.31% 40/285 |
- - |
- - |
- - |
- - |
| 2016 | -12.83% 81/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 富国文体健康股票A VS. 东吴新产业精选股票A(580008) |